BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2989312)

  • 1. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
    J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay and enzyme-linked immunoassay of antibodies directed against lymphadenopathy-associated virus (LAV) proteins larger than the core protein (P24).
    Neurath AR; Strick N; Lee YS; Nilsen T; Baker L; Sproul P; Rubinstein P; Taylor P; Stevens CE; Gold JW
    J Virol Methods; 1985 Oct; 12(1-2):85-92. PubMed ID: 3001122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological characterization of HTLV-III infection in AIDS and related disorders.
    Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S
    J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.
    Casey JM; Kim Y; Andersen PR; Watson KF; Fox JL; Devare SG
    J Virol; 1985 Aug; 55(2):417-23. PubMed ID: 2410630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
    Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
    Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.
    Schüpbach J; Popovic M; Gilden RV; Gonda MA; Sarngadharan MG; Gallo RC
    Science; 1984 May; 224(4648):503-5. PubMed ID: 6200937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.
    Hunsmann G; Schneider J; Bayer H; Kurth R; Werner A; Brede HD; Erfle V; Mellert W; Brodt HR; Bergmann L
    Klin Wochenschr; 1985 Mar; 63(5):233-5. PubMed ID: 2985862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).
    Kanki PJ; Barin F; M'Boup S; Allan JS; Romet-Lemonne JL; Marlink R; McLane MF; Lee TH; Arbeille B; Denis F
    Science; 1986 Apr; 232(4747):238-43. PubMed ID: 3006256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human retroviral env and gag polypeptides: serologic assays to measure infection.
    Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS
    J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.
    Blumberg RS; Sandstrom EG; Paradis TJ; Neumeyer DN; Sarngadharan MG; Hartshorn KL; Byington RE; Hirsch MS; Schooley RT
    J Clin Microbiol; 1986 Jun; 23(6):1072-7. PubMed ID: 2423552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
    Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
    Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.
    Kalyanaraman VS; Cabradilla CD; Getchell JP; Narayanan R; Braff EH; Chermann JC; Barré-Sinoussi F; Montagnier L; Spira TJ; Kaplan J
    Science; 1984 Jul; 225(4659):321-3. PubMed ID: 6330889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
    Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
    J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
    Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
    Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.